How long can resistance to Platinib last?

How long resistance to platinib can last is a complex question, and the answer varies from individual to individual. Platinib, as a targeted drug, is mainly used to treat RET fusion-positive non-small cell lung cancer and other cancers. However, some patients may develop resistance to platinib over time.

The patient's disease stability and physical fitness are important factors that affect the maintenance time of platinib. Patients with stable disease and good physical fitness may be able to maintain Platinib for a longer period of time. Different patients have different abilities to absorb and metabolize platinib, which will also affect the maintenance time of the drug. In patients with strong absorption and metabolism abilities, the drug may last longer in the body.

The resistance mechanism of platinib may involve multiple factors, such as secondary mutations of the RET gene, activation of other signaling pathways, etc. These changes may lead to reduced sensitivity of tumor cells to platinib, resulting in drug resistance.

According to clinical research data, the resistance time to platinib varies among individuals. Some patients may develop resistance to platinib within months of taking it, while others may develop resistance years later. Therefore, the exact duration of resistance cannot be given.

In order to detect drug resistance in time, patients should undergo relevant examinations regularly, such as tumor marker testing, imaging examinations, etc. These examinations help evaluate treatment effects and detect changes in condition in a timely manner.

Once drug resistance occurs, patients should communicate with their doctors in a timely manner and adjust the treatment plan according to the specific situation. This may include switching to other targeted drugs, combination chemotherapy or immunotherapy, etc.